ARPA-H announced it will grant up to $125 million to projects aimed at accelerating the manufacturing of custom RNA-based ...

FDA further tests waters on AI medical devices; Ultragenyx sees its stock crater on Phase 3 trial failure; Brain implants ...

The agency said booth materials for Alar’s investigational ALA-3000 made unsupported safety and efficacy claims and failed to ...

Meet the latest partners in Trump’s MFN pricing agreements; Novartis’ roller coaster day; Inside the perimenopause industrial ...

A major MFN pricing loophole; An uptick in parents opting out of vitamin K shots for newborns; BI leans into AI-powered drug ...

The Current, Gulf States Newsroom, and Verite News — to ask all 64 sheriffs in the state how they’ve spent their opioid ...

Omnicom Public Relations Group firm Maslansky + Partners named Keith Yazmir president and Katherine Hettrich and Amanda ...

Built in collaboration with Google Cloud, Eversana’s platform combines agentic AI orchestration, workflow automation and ...

Novo and Lilly step up fight against counterfeit weight-loss drugs; Updated COVID shots enter the scene; Walmart settles for ...

RNA technology gets public image lift; Lilly acquires another biotech; GOP gambles midterm fortunes on MAHA movement.

FDA approves Revolution Medicines’ high profile pancreatic cancer drug; Major drugmakers try to claim stake in new ...